compare tirzepatide vs semaglutide for weight loss Tirzepatide vs Semaglutide: Ultimate Weight

Wegovy has a safety advantage for people without gallbladders compared to some alternatives

Following the success of the SELECT trial, Wegovy (semaglutide in doses of 1.7 mg and 2.4 mg) received a similar approval in March 2024 for people with overweight or obesity and cardiovascular disease

On the 25th, the Guardian in the UK reviewed the side effects reported so far with major obesity treatments, along with the scientific evidence behind them

If your insurance covers semaglutide for weight loss, your out-of-pocket cost may be as low as $25 to $200 per month, depending on your plan and the terms of coverage

In conclusion, semaglutide combined with lifestyle intervention not only reduces body weight but also effectively improves body composition and associated metabolic abnormalities in obese patients